Status:
COMPLETED
Peri Tonsillar Infiltration of Ketamine or Bupivacaine for Post Tonsillectomy Analgesia
Lead Sponsor:
Sohag University
Conditions:
Post Operative Pain
Eligibility:
All Genders
3-20 years
Phase:
PHASE4
Brief Summary
Comparison between the analgesic effect of local infiltration of either Bupivacaine or ketamine in the peritonsillar area before the incision of tonsillectomy to achieve postoperative analgesia
Eligibility Criteria
Inclusion
- Inclusion criteria
- 3-20 years old patients
- elective tonsillectomy or adenotonsillectomy with or without ventilation tube application.
- Exclusion criteria
- allergy to bupivacaine or ketamine
- coagulopathy
- endocrine, neuropsychiatric or cardiopulmonary dysfunction
- increase intracranial pressure (ICP)
- psychiatric illness, history of seizure, patients under chronic analgesic treatment
- history of peritonsillar abscess, tonsillar malignancy.
Exclusion
Key Trial Info
Start Date :
April 2 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 2 2022
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05341323
Start Date
April 2 2022
End Date
July 2 2022
Last Update
July 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag Faculty of Medicine
Sohag, Egypt